Condition: Healthy Subjects · Sponsor: Daewoong Pharmaceutical Co. LTD.
Interested? Contact the study team ↓
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
This description comes directly from the study's public registry record.
Kang · 82) 070-4665-9490 · juspa@newyjh.com
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Male or female participants aged ≥19 years and \<65 years at the time of screening * Body mass index (BMI) between 18 and 30 kg/m² (BMI = weight \[kg\] / height \[m\]²) Exclusion Criteria: * Subjects who have participated in a bioequivalence study or any other clinical trial and have received an investigational product within 6 months prior to the first administration. * Subjects who have donated whole blood within 8 weeks prior to the first administration, donated blood components within 2 weeks prior to the first administration, or received a blood transfusion within 4 weeks prior to the first administration. * Subjects with a history of gastrointestinal surgery that may affect drug absorption (appendectomy and hernia repair are not exclusionary).
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| H Plus Yangji Hospital | Seoul, South Korea | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.